Quality ID
116NQF
0058High Priority Measure
YesSpecifications
RegistryMeasure Type
ProcessRegistry Link
RegistrySpecialty
Emergency Medicine Family Medicine Infectious Disease Preventive MedicineMeasure description
The percentage of adults 18–64 years of age with a diagnosis of acute bronchitis who were not prescribed or dispensed an antibiotic prescription
Instructions
This measure is to be submitted at each occurrence of acute bronchitis during the performance period. This measure may be submitted by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
Measure Submission:
The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data.
Denominator
All patients aged 18 through 64 years of age with an outpatient, observation or emergency department (ED) visit with a diagnosis of acute bronchitis during the measurement period
DENOMINATOR NOTE: To determine eligibility, look for any of the listed antibiotic drugs below in the 30 days prior to the visit with the acute bronchitis diagnosis. As long as there are no prescriptions for the listed antibiotics during this time period, the patient is eligible for denominator inclusion. Do not include observation or ED visits that result in an inpatient admission. An observation or ED visit results in an inpatient admission when the observation or ED date of service and the admission date for the inpatient stay are one calendar day apart or less.
*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for registry-based measures.
Denominator Criteria (Eligible Cases):
Patients18 through 64 years of age on date of encounter
AND
Diagnosis for acute bronchitis (ICD-10-CM): J20.3, J20.4, J20.5, J20.6, J20.7, J20.8, J20.9
AND
Patient encounter during the performance period (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99217, 99218, 99219, 99220, 99281, 99282, 99283, 99284, 99285, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99381, 99382, 99383, 99384, 99385, 99386, 99387, 99391, 99392, 99393, 99394, 99395, 99396, 99397, 99401, 99402, 99403,99404, 99411, 99412, 99420, 99429 ,99455, 99456, G0402, G0438, G0439, G0463*, T1015*
AND NOT
DENOMINATOR EXCLUSIONS:
Observation or ED visits that result in an inpatient admission
OR
Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, Lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/UTI, acne, HIV disease/asymptomatic HIV, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis: G9712
OR
Patients who use hospice services any time during the measurement period: G9713
Numerator
Patients who were not prescribed or dispensed antibiotics on or within 3 days of the initial date of service
Numerator Instructions: For performance, the measure will be calculated as the number of patient encounters where antibiotics were neither prescribed nor dispensed on or within 3 days of the episode for acute bronchitis over the total number of encounters in the denominator (patients aged 18 through 64 years with an outpatient, observation or ED visit for acute bronchitis). A higher score indicates appropriate treatment of patients with acute bronchitis (e.g., the proportion for whom antibiotics were not prescribed or dispensed on or three days after the encounter).
Antibiotic Medications
Description | Prescription |
|
Aminoglycosides | Amikacin | Kanamycin |
Aminopenicillins | Amoxicillin | Ampicillin |
Antipseudomonal penicillins | Piperacillin | |
Beta-lactamase inhibitors | Amoxicillin-clavulanate | Piperacillin-tazobactam |
First-generation cephalosporins | Cefadroxil | Cefazolin |
Fourth-generation cephalosporins | Cefepime | |
Ketolides | Telithromycin | |
Lincomycin derivatives | Clindamycin | |
Macrolides | Azithromycin | Erythromycin |
Miscellaneous antibiotics | Aztreonam | Daptomycin |
Natural penicillins | Penicillin G sodium benzathineprocaine | Penicillin V potassium |
Penicillinase resistant penicillins | Dicloxacillin | Nafcillin |
Quinolones | Ciprofloxacin | Levofloxacin |
Rifamycin derivatives | Rifampin | |
Second generation cephalosporin | Cefaclor | Cefoxitin |
Sulfonamides | Sulfadiazine | Sulfamethoxazole-trimethoprim |
Tetracyclines | Doxycycline | Minocycline |
Third generation cephalosporins | Cefdinir | Cefotaxime |
Urinary anti-infectives | Fosfomycin | Nitrofuantoin |
Numerator Options:
Performance Met: Antibiotic neither prescribed nor dispensed (4124F)
OR
Performance Not Met: Antibiotic prescribed or dispensed (4120F)